39,934 Shares in Tempus AI, Inc. $TEM Purchased by Bouvel Investment Partners LLC

Key Points

• Bouvel Investment Partners LLC acquired nearly 40,000 shares in Tempus AI, Inc. valued at approximately $2.5 million during the second quarter.
• Insider trading activity has been reported, with CFO James William Rogers and EVP Andrew Polovin selling shares worth over $960,000 combined, reducing their positions by 5.16% and 3.93%, respectively.
• Tempus AI's quarterly earnings beat estimates, reporting revenue of $314.64 million, a significant 89.5% increase year-over-year despite a negative EPS of ($0.22).

Bouvel Investment Partners LLC purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 39,934 shares of the company's stock, valued at approximately $2,537,000.

Several other large investors also recently bought and sold shares of TEM. Cherry Tree Wealth Management LLC purchased a new position in shares of Tempus AI during the 1st quarter worth approximately $31,000. University of Texas Texas AM Investment Management Co. purchased a new position in Tempus AI during the 1st quarter worth $33,000. Continuum Advisory LLC acquired a new position in Tempus AI in the first quarter valued at $39,000. Bartlett & CO. Wealth Management LLC increased its stake in Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after purchasing an additional 400 shares during the period. Finally, Nemes Rush Group LLC acquired a new position in shares of Tempus AI during the first quarter worth about $39,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Insiders Place Their Bets

In related news, EVP Erik Phelps sold 3,664 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $273,517.60. Following the completion of the sale, the executive vice president directly owned 94,115 shares of the company's stock, valued at approximately $7,025,684.75. This represents a 3.75% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO James William Rogers sold 7,528 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the completion of the sale, the chief financial officer directly owned 138,473 shares of the company's stock, valued at $10,337,009.45. The trade was a 5.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 601,787 shares of company stock worth $42,492,268 in the last three months. 26.27% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms recently commented on TEM. Guggenheim boosted their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Bank of America upped their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Needham & Company LLC reiterated a "buy" rating and issued a $70.00 price target on shares of Tempus AI in a report on Friday, August 8th. BTIG Research increased their price objective on shares of Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a research report on Wednesday, August 20th. Finally, Piper Sandler restated a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. Seven analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, Tempus AI currently has a consensus rating of "Moderate Buy" and an average target price of $70.17.

Tempus AI Trading Down 0.8%

TEM traded down $0.70 during trading on Tuesday, hitting $85.17. The company's stock had a trading volume of 6,523,480 shares, compared to its average volume of 12,223,968. The firm has a market capitalization of $14.80 billion, a P/E ratio of -71.56 and a beta of 5.07. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $97.79. The stock's fifty day moving average price is $71.02 and its 200-day moving average price is $61.08. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The firm had revenue of $314.64 million for the quarter, compared to analysts' expectations of $296.84 million. During the same period in the prior year, the business earned ($6.86) EPS. The company's revenue for the quarter was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. Analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.